SIFASI HP 5000 I.U

Overview of SIFASI HP 5000 I.U.

SIFASI HP 5000 I.U. is a medicinally active form of human pregnancy hormone known as hCG, which is synthetically produced in laboratories and offered in injectable form. As a prescription medication, SIFASI HP 5000 I.U. is designed to promote fertility in women, mainly through regulating ovulation and stimulating ovaries to produce eggs. SIFASI HP 5000 I.U. is developed with the highest of quality standards, ensuring patients of increased efficiency and efficacy, with minimal side effects. It offers excellent value, with a cost-effective approach to fertility treatments.

Pharmacological Properties of SIFASI HP 5000 I.U.

SIFASI HP 5000 I.U. contains an active form of human chorionic gonadotropin (hCG), which is a hormone produced by the placenta during pregnancy. The main purpose of hCG is to maintain the pregnancy by promoting the production of progesterone. In the body, hCG works as a booster for luteinizing hormone (LH) and follicle stimulating hormone (FSH)– two hormones that regulate ovulation and stimulate the maturation and release of an egg from the ovary. SIFASI HP 5000 I.U. has been found to be effective in inducing ovulation during fertility treatment, and has been studied to be safe and effective when used in combination with gonadotropins.

Indications of Using SIFASI HP 5000 I.U.

SIFASI HP 5000 I.U. is prescribed to female patients for fertility treatments, by inducing ovulation. It is highly indicated in women who are unable to conceive due to issues such as polycystic ovarian syndrome (PCOS) and oligo-ovulation.

Contraindications to Using SIFASI HP 5000 I.U.

In some cases, SIFASI HP 5000 I.U. may not be suitable for certain women. It should be avoided in cases of:

• Allergic reaction to hCG
• High levels of estrogen
• Obstructive condition of the Fallopian tubes
• Presence of liver or kidney impairment
• Unidentified or unexplained infertility
• Underactive pituitary glands
• Cancer of the reproductive system

Dosage of SIFASI HP 5000 I.U.

SIFASI HP 5000 I.U. is administered as an intramuscular injection at a dosage of 1 to 2 vials per cycle. It should be injected one to two days after the start of menstruation cycle and treatment should be continued for 8 to 10 days.

Possible Side Effects and Overdose of SIFASI HP 5000 I.U.

SIFASI HP 5000 I.U. may cause a few side effects and certain allergic reactions. Common side effects include headache, dizziness, bloating, stomach pain, stubborn acne, tender breasts, constipation, appetite disturbances, breast enlargement, and nausea. In case of a known overdose, patients should seek immediate medical attention. Do not use more than the prescribed dosage.

Value Offered by SIFASI HP 5000 I.U.

SIFASI HP 5000 I.U. is an effective injectable form of human chorionic gonadotropin (hCG) medication that provides women of reproductive age with multiple benefits, such as:

• Safe and Efficient: Clinically proven to be a safe and efficient medication for fertility treatment, with minimal side effects.
• Cost-effective: Offers effective fertility treatments at a lower cost than other commonly prescribed fertility drugs.
• High-quality: Produced with the highest of quality standards, offering patients the assurance of reliable and pure goodness.

SIFASI HP 5000 I.U. is an ideal choice for all women seeking fertility treatments. It offers an excellent value proposition– safe, efficient and cost-effective.